Testing effectiveness (Phase 2)Study completedNCT03126019What this trial is testingINCB050465 in Relapsed or Refractory Follicular LymphomaWho this might be right forLymphoma Incyte Corporation 126
Testing effectiveness (Phase 2)Looking for participantsNCT07372365What this trial is testingOrelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.Who this might be right forMarginal Zone Lymphoma (MZL) The First Affiliated Hospital of Soochow University 23
Testing effectiveness (Phase 2)UnknownNCT00568607What this trial is testingStudy on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell LymphomaWho this might be right forLymphoma Fudan University 60
Large-scale testing (Phase 3)Study completedNCT03976102What this trial is testingCompare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular LymphomaWho this might be right forFollicular Lymphoma Dr. Reddy's Laboratories Limited 317
Not applicableLooking for participantsNCT06509945What this trial is testingAllo-PBSCT as the First-line Treatment for Patients With the High-risk PTCLWho this might be right forPeripheral T Cell Lymphoma Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04842877What this trial is testingStudy of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell LymphomaWho this might be right forLymphoma, B-Cell The Lymphoma Academic Research Organisation 141
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Early research (Phase 1)Looking for participantsNCT06547528What this trial is testingA Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLLWho this might be right forRelapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Ono Pharmaceutical Co., Ltd. 108
Large-scale testing (Phase 3)Ended earlyNCT00056056What this trial is testingUltraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis FungoidesWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 93
Testing effectiveness (Phase 2)Study completedNCT02433795What this trial is testingBendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)Who this might be right forMarginal Zone B-cell Lymphoma Seoul National University Hospital 27
Not applicableEnded earlyNCT00161239What this trial is testingLAMPP Trial for Peripheral and Cutaneous T-Cell LymphomaWho this might be right forT-Cell Lymphoma University of Medicine and Dentistry of New Jersey 64
Not applicableStudy completedNCT06798428What this trial is testingFor Grade I and II Knee Meniscal Injuries Patients ,Glucosamine, Chondroitin and Some Herbs Extract Phonophoresis Will Be Used (A) Versus Placebo(B)Who this might be right forGrade I and II Knee Meniscal Injuries Eslam Elsayed Ali Shohda 45
Not applicableUnknownNCT00429065What this trial is testingTreatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.Who this might be right forNon-Hodgkin Lymphoma Instituto Nacional de Cancerologia de Mexico 30
Testing effectiveness (Phase 2)Ended earlyNCT00727207What this trial is testingEverolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line ChemotherapyWho this might be right forLymphoma Technical University of Munich 35
Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237What this trial is testingTesting Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more Eastern Cooperative Oncology Group
Not applicableStudy completedNCT01904175What this trial is testingRegistry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell TransplantWho this might be right forHodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more Duke University 48
Testing effectiveness (Phase 2)Ended earlyNCT01699581What this trial is testingAssessment of Impact Nutritional Program During Autologous Stem Cell TransplantWho this might be right forHodgkin's LymphomaMultiple MyelomaNon-Hodgkin's Lymphoma Greg Monohan 35
Early research (Phase 1)Study completedNCT03498430What this trial is testingCopanlisib Chinese PK StudyWho this might be right forLymphoma, Non-Hodgkin Bayer 13
Large-scale testing (Phase 3)Study completedNCT00329030What this trial is testingRituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)Who this might be right forLymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin National Heart, Lung, and Blood Institute (NHLBI) 224
Not applicableNot Yet RecruitingNCT06720207What this trial is testingEfficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma LesionsWho this might be right forNon Hodgkin's LymphomaMultiple Myeloma (MM) Shanghai East Hospital 30